Treatment of Diabetic Retinopathy
- Conditions
- Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
- Registration Number
- CTRI/2023/03/050271
- Lead Sponsor
- GSVM MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 52
PATIENTS DIAGNOSED WITH TYPE 2 DIABETES MELLITUS WITH MILD AND MODERATE DIABETIC RETINOPATHY
PATIENTS NOT WILLING TO PARTICIPATE OR READY FOR FOLLOW UP.
PATIENTS HAVING SEVERE DIABETIC RETINOPATHY,PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA.
PATIENTS WITH UNCONTROLLED DIABETES.
PATIENTS WITH ANY OCULAR INFECTION,RAISED INTRAOCULAR PRESSURE,ANY CORNEAL PATHOLOGY,THINNED SCLERA,SCLERITIS,STAPHYLOMA OR ANY OTHER ANTERIOR SEGMENT PATHOLOGY EXCEPT PSEUDOPHAKIC PATIENTS.
PATIENTS DIAGNOSED OF ANY OTHER RETINAL OR VITREOUS PATHOLOGIES EXCEPT DIABETIC RETINOPATHY.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IMPROVEMENT IN VISUAL ACUITYTimepoint: 3-6 MONTHS
- Secondary Outcome Measures
Name Time Method CATARCTTimepoint: 6 MONTHS- 1 YEAR;CHOROIDAL/RETINAL DETACHMENTTimepoint: 1 DAY;DECREASE IN VISUAL ACUITYTimepoint: 1 DAY- 1YEAR;RAISED INTRAOCULAR PRESSURETimepoint: 1-5 DAYS;VITRITIS/ ENDOPHTHALMITISTimepoint: 15 DAYS